Who
Eric S. Fain
Director
Company insider
Files Form 4 as: Director, Orchestra BioMed Holdings; Senior Vice President, Abbott Laboratories; Group President, St Jude Medical.
In numbers
- Trades disclosed
- 275
- Buys
- 2
- Sells
- 19
- Bought
- $180K
- Sold
- $31.6M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 1 Jul 2007
- Last trade
- 12 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Aug 2026filed 14 Aug 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $23K5,145 at $4.42 | filing |
| 12 Aug 2026filed 14 Aug 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $23K5,145 at $4.42 | filing |
| 24 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | —4,261 at $0.00 | filing |
| 24 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | —4,261 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —17,327 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —21,277 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —21,277 at $0.00 | filing |
| 23 Jun 2026filed 25 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —17,327 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $83K20,000 at $4.13 | filing |
| 14 May 2026filed 18 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $83K20,000 at $4.13 | filing |
| 25 Aug 2025filed 25 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $15K5,760 at $2.61 | filing |
| 7 Aug 2025filed 8 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 7 Aug 2025filed 8 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 26 Jun 2025filed 27 Jun 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Sold | $8,1832,683 at $3.05 | filing |
| 24 Jun 2025filed 26 Jun 2025 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —36,797 at $0.00 | filing |
| 24 Jun 2025filed 26 Jun 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —12,422 at $0.00 | filing |
| 10 Sep 2024filed 10 Sep 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Sold | $9,6121,800 at $5.34 | filing |
| 9 Sep 2024filed 10 Sep 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Sold | $9,7741,800 at $5.43 | filing |
| 6 Sep 2024filed 10 Sep 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Sold | $11K2,000 at $5.64 | filing |
| 20 Jun 2024filed 21 Jun 2024 | OBIO Orchestra BioMed Holdingsoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,068 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.